New Horizon Capital

New Horizon Capital is a top-tier private equity fund focused on investing in China.

Business Model:

Revenue: $26.2M

Employees: 201-500

Rankings

Detailed New Horizon Capital Information

Geographic Data

New Horizon Capital headquarters map

Address: Room 1702-1703, Building 1, No. 8 Exchange Square

City: Hong Kong

State: other

Zip:

Country: HK

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

New Horizon Capital is a top-tier private equity fund focusing on investing in china. It was incorporated in Cayman Islands in May 2005 with two limited partners: Tamasek Holdings Private Limited and SBI Holdings Inc. They currently manage over approximately $2.5 billion RMB and USD funds. Their LPs include more than 20 internationally renowned institutions The Fund is managed by a group of highly professional and experienced staff who have very strong business sense to identify and capture various investment opportunities. The firm invests in companies in consumer &a; retail, alternative energy, pharmaceutical &a; healthcare and advanced manufacturing sectors. It makes investment either through purchase of non-tradable stocks of domestic listed company or equity interest in private company at expansion stage. China&s;s rapid economic growth in the context of the Fund&s;s investment and participation in the target company will bring rapid and stable development, to bring investors good returns and also benefit the local government, in order to achieve multi-win-win situation.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
5/2016 GoGoX Series C -
9/2016 Genetron Health Series B -
7/2015 Huitongda Series A 80.8M
12/2015 Wochu.cn Series A 1.5M
5/2016 Chuchujie Series C 153.9M
12/2013 Punch Powertrain Private Equity Round -
4/2015 Kakao Series A -
10/2013 Orbiepharm Angel Round 490.2k
10/2016 Xueleyun Series C 0
5/2015 Bochewang Series A 16.2M
1/2015 BeiBei Series C 0
7/2017 Qiagen Suzhou Translational Medicine Series A 0
7/2019 Ke.com Series D 0
10/2016 NeoBear Series B 37M
6/2016 BeiBei Series D 100M
10/2013 Chukong Technologies Series D 0
4/2014 Arrail Dental Clinic Series C 70M
8/2015 HS Entertainment Series B 3.2M
7/2021 KK Group Series F 0
1/2015 Zailushang Series B -
5/2017 Wacai.com Series C 0
7/2015 Zhaolu Tianxia Wang Series B 3.2M
7/2015 Wacai.com Series B 80M
10/2013 Kuaidi Dache Series B 100M
4/2015 HuaKang Mobile Healthcare Series B 32M
1/2016 TalkingData Series C -
11/2016 Moviebook Series C -
1/2014 Wangxiangyuan Series A 19.6M
4/2019 Energy Monster Series C 0
7/2016 Pinduoduo Series B 110M
10/2016 Xuele Zhongguo Series C 200M
3/2015 Yuanfudao Series D 60M
7/2014 Jinko Solar Post-IPO Equity 225M
7/2021 KK Group Series F 0
7/2019 Ke.com Series D 0
4/2019 Energy Monster Series C 0
7/2017 Qiagen Suzhou Translational Medicine Series A 0
5/2017 Wacai.com Series C 0
11/2016 Moviebook Series C -
10/2016 NeoBear Series B 0
10/2016 Xueleyun Series C 0
10/2016 Xuele Zhongguo Series C 0
9/2016 Genetron Health Series B -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research